Transport and biodistribution of dendrimers across human fetal membranes: Implications for intravaginal administration of dendrimer-drug conjugates

Biomaterials

Volumn 31, Issue 18, 2010, Pages 5007-5021

  Menjoge, Anupa R ^a,b   Navath, Raghavendra S ^a,b   Asad, Abbas ^b   Kannan, Sujatha ^c   Kim, Chong J ^b   Romero, Roberto ^b   Kannan, Rangaramanujam M ^a,b  

^a Wayne State University   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

Biodistribution; Chorioamnion; Dendrimers; Membrane permeability; Nanotoxicology; Topical intravaginal; Transplacental transport

Indexed keywords

ANTI-MICROBIAL AGENT; BIODISTRIBUTION; BIODISTRIBUTIONS; DIFFUSION CHAMBER; DRUG DELIVERY VEHICLES; DRUG-CONJUGATES; EX-VIVO; FETAL MEMBRANES; HPLC ANALYSIS; INTERSTITIAL SPACE; MALDI TOF MS; MEMBRANE PERMEABILITY; NANO SCALE; NANOTOXICOLOGY; PAMAM DENDRIMER; PARACELLULAR TRANSPORT; PASSIVE DIFFUSIONS; POLY(AMIDO AMINE); PREGNANT WOMAN; STROMAL CELLS;

CAPILLARITY; CYTOLOGY; DENDRIMERS; DRUG DELIVERY; FLUOROPHORES; MEMBRANES; MICROORGANISMS; SYNTHESIS (CHEMICAL);

FUNCTIONAL POLYMERS;

DENDRIMER; DRUG; POLYAMIDOAMINE;

ARTICLE; CONTROLLED STUDY; DECIDUA; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; EX VIVO STUDY; FEMALE; FETUS; FETUS MEMBRANE; HUMAN; HUMAN TISSUE; INTERNALIZATION; MEMBRANE PERMEABILITY; PRIORITY JOURNAL; STROMA CELL; TRANSPORT KINETICS; TROPHOBLAST;

AMNION; BIOLOGICAL TRANSPORT; CHORION; DENDRIMERS; FEMALE; HUMANS; PREGNANCY;

EID: 77951975238     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.02.075     Document Type: Article

References (73)

1. Audus K.L. Controlling drug delivery across the placenta. Eur J Pharm Sci 1999, 8(3):161-165.
2. Nicolle L.E. Use of antimicrobials during pregnancy. Can Fam Physician 1987, 33:1247-1251.
3. Sastry B.V. Techniques to study human placental transport. Adv Drug Deliv Rev 1999 14, 38(1):17-39.
4. Ndesendo V.M., Pillay V., Choonara Y.E., Buchmann E., Bayever D.N., Meyer L.C. A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections. AAPS PharmSciTech 2008, 9(2):505-520.
5. Chaim W., Mazor M., Leiberman J.R. The relationship between bacterial vaginosis and preterm birth. A review. Arch Gynecol Obstet 1997, 259:51-58.
6. Soong D., Einarson A. Vaginal yeast infections during pregnancy. Can Fam Physician 2009, 55:255-256.
7. Ugwumadu A. Role of antibiotic therapy for bacterial vaginosis and intermediate flora in pregnancy. Best Pract Res Clin Obstet Gynaecol 2007, 21(3):391-402.
8. Romero R., Chaiworapongsa T., Espinoza J. Micronutrients and intrauterine infection, preterm birth and the fetal inflammatory response syndrome. J Nutr 2003, 1668S-1673S.
9. Stone A. Microbicides: a new approach to preventing HIV and other sexually transmitted infections. Nat Rev Drug Discov 2002, 1(12):977-985.
10. Lebreton S., Newcombe N., Bradley M. Antibacterial single-bead screening. Tetrahedron 2003, 59:10213-10222.
11. Balogh L., Swanson D.R., Tomalia D.A., Hagnauer G.L., McManus A.T. Dendrimer-Silver complexes and nanocomposites as antimicrobial agents. Nano Lett 2001, 1:18-21.
12. Cheng Y., Qu H., Ma M., Xu Z., Xu P., Fang Y., et al. An in vitro study Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials. Eur J Med Chem 2007, 42:1032-1038.
13. Devarakonda B., Li N., deVilliers M.M. Effect of Polyamidoamine (PAMAM) dendrimers on the in vitro release of water-insoluble nifedipine from aqueous gels. AAPS PharmSciTech 2005, 6(3):504-512.
14. Unal B., Hedden R.C. pH-dependent swelling of hydrogels containing highly branched polyamine macromonomers. Polymer 2009, 50:905-912.
15. Wu X., Huang S.W., Zhang J.T., Zhuo R.X. Preparation and characterization of novel physically cross-linked hydrogels composed of poly (vinyl alcohol) and amine-terminated polyamidoamine dendrimer. Macromol Biosci 2004, 4:71-75.
16. Patton D.L., Cosgrove Sweeney Y.T., McCarthy T.D., Hillier S.L. Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model. Antimicrobial Agents Chemother 2006, 50(5):1696-1700.
17. Mumper R.J., Bell M.A., Worthen D.R., Cone R.A., Lewis G.R., Moench T.R. Formulating a sulfonated anti-viral dendrimer in a vaginal microbicidal gel having dual mechanisms of action. Drug Dev Ind Pharm 2009, 35(5):515-524.
18. Svenson S., Tomalia D.A. Dendrimers in biomedical applications-reflections on the field. Adv Drug Deliv Rev 2005, 57(15):2106-2129.
19. Bernstein D., Stanberry L.R., Sacks S., Ayisi N.K., Gong Y.H., Ireland J., et al. Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes. Antimicrob Agents Chemother 2003, 47(12):3784-3788.
20. http://clinicaltrials.gov/ct2/results%3Fterm%3DSPL7013.
21. Calabretta M.K., Kumar A., McDermott A.M., Cai C. Antibacterial activities of Poly (amidoamine)dendrimers terminated with amino and poly (ethylene glycol) groups. Biomacromolecules 2007, 8:1807-1811.
22. Tulu M., Aghatabay N.M., Senel M., Dizman C., Parali T., Dulger B. Synthesis, characterization and antimicrobial activity of water soluble dendritic macromolecules. Eur J Med Chem 2009, 44:1093-1099.
23. Ortega P., Copa-Patino J.L., Munoz-Fernandez M.A., Soliveri J., Gomez R., Mata F.J. Amine and ammonium functionalization of chloromethylsilane-ended dendrimers: antimicrobial activity studies. Org Biomol Chem 2008, 6:3264-3269.
24. Chen C.Z., Cooper S.L. Interactions between dendrimer biocides and bacterial membranes. Biomaterials 2002, 23:3359-3368.
25. Chen C.Z., Beck-Tan N.C., Dhurjati P., Van Dyk T.K., LaRossa R.A., Cooper S.L. Quaternary ammonium functionalized Poly(propylene imine) dendrimers as effective antimicrobials: structure-activity studies. Biomacromolecules 2000, 1:473-480.
26. Cloninger M.J. Biological applications of dendrimers. Curr Opin Chem Biol 2002, 6:742-748.
27. Rosenstein I.J., Morgan D.J., Lamont R.F., Sheehan M., Dor C.J., Hay P.E., et al. Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women. Infect Dis Obstet Gynecol 2000, 8:158-165.
28. Drake S., Taylor S., Brown D., Pillay D. Improving the care of patients with genital herpes. BMJ 2000, 321(9):619-623.
29. Ylikorkala O., Sjöstedt E., Järvinen P.A., Tikkanen R., Raines T. Trimethoprim-sulfonamide combination administered orally and intravaginally in the first trimester of pregnancy: its absorption into serum and transfer to amniotic fluid. Acta Obstet Gynecol Scand 1973, 52:229-234.
30. and http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm%3Fid%3D8383.
31. Sosnik A., Chiappetta D.A., Carcaboso Á M. Drug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing ahead. J Control Release 2009, 138:2-15.
32. http://clinicaltrials.gov/ct2/show/NCT00540605.
33. Cheng Y., Man N., Xu T., Fu R., Wang X., Wang X., et al. Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers. J Pharm Sci 2007, 96(3):595-602.
34. Chauhan A.S., Sridevi S., Chalasani K.B., Jain A.K., Jain S.K., Jain N.K., et al. Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. J Control Release 2003, 90(3):335-343.
35. Kim S.S., Romero R., Kim J.S., Abbas A., Espinoza J., Kusanovic J.P., et al. Coexpression of myofibroblast and macrophage markers: novel evidence for an in vivo plasticity of chorioamniotic mesodermal cells of the human placenta. Lab Invest 2008, 88:365-374.
36. Zheng Y., Qiu Y., Lu M.F., Hoffman D., Reiland T.L. Permeability and absorption of leuprolide from various intestinal regions in rabbits and rats. Int J Pharm 1999, 185:83-92.
37. Myllynena P., Loughran M.J., Howard C.V., Sormunen R., Walsh A.A., Vähäkangas K.H. Kinetics of gold nanoparticles in the human placenta. Reprod Toxicol 2008, 26:130-137.
38. Miller R., Mace K., Polliotti B., DeRita R., Hall W., Treacy G. Marginal transfer of ReoProe (Abciximab) compared with immunoglobulin G (F105), inulin and water in the perfused human placenta in vitro. Placenta 2003, 24:727-738.
39. Kurtoglu Y.E., Mishra M.K., Kannan S., Kannan R.M. Drug release characteristics of PAMAM dendrimer-drug conjugates with different linkers. Int J Pharm 2009, 384:189-194.
40. Saunders M. Transplacental transport of nanomaterials. Adv Rev 2009, 1:671-684.
41. Bajoria R., Contractor S.F. Effect of size of liposomes on transplacental transfer of carboxyfluorescein across the perfused human term placenta. J Pharm Pharmacol 1997, 49:675-681.
42. Bajoria R., Contractor S.F. Effect of surface charge of small unilamellar liposomes on uptake and placental transfer of carboxyfluorescein. Pediatr Res 1997, 42:520-527.
43. Bajoria R., Sooranna S.R. Liposome as a drug carrier system: prospects for safer prescribing during pregnancy. Trophoblast Res 1998, 12:265-287.
44. Liu F., Soares M.J., Kenneth L.A. Permeability properties of monolayers of the human trophoblast cell line BeWo. Am J Physiol, Cell Physiol 1997, 273:1596-1604.
45. Ampasavate C., Chandorkar G.A., Velde D.G.V., Stobaugh J.F., Audus K.L. Transport and metabolism of opioid peptides across BeWo cells, an in vitro model of the placental barrier. Int J Pharm 2002, 233:85-98.
46. Powell T.L., Jansson T., Illsley N.P., Wennergren M., Korotkova M., Strandvik B. Composition and permeability of syncytiotrophoblast plasma membranes in pregnancies complicated by intrauterine growth restriction. Biochim Biophys Acta 1999, 1420:86-94.
47. Giri J., Diallo M.S., Goddard W.A., Dalleska N.F., Tang X.F.Y. Partitioning of poly(amidoamine) dendrimers between n-octanol and water. Environ Sci Technol 2009, 43:5123-5129.
48. Battaglia F., Bruns P.D., Behrman R.E., Seeds A.E., Hellegers A.E. Comparison of permeability of different layers of the primate placenta to d-arabinose and urea. Am J Phys 1964, 2007(2):500-502.
49. Poletto F.S., Jäger E., Cruz L., Pohlmann A.R., Guterres S.S. The effect of polymeric wall on the permeability of drug-loaded nanocapsules. Mater Sci Eng C 2008, 28(4):472-478.
50. Beall M.H., van den Wijngaard J.P.H.M., van Gemert M.J.C., Ross M.G. Amniotic fluid water dynamics. Placenta 2007, 28:816-823.
51. Ye Z., Rombout P., Remon J.P., Vervaet C., Van den Mooter G. Correlation between the permeability of metoprolol tartrate through plasticized isolated ethylcellulose/hydroxypropyl methylcellulose films and drug release from reservoir pellets. Eur J Pharm Biopharm 2007, 67:485-490.
52. Gholap S., Jog J.P., Badiger M.V. Synthesis and characterization of hydrophobically modified poly(vinyl alcohol) hydrogel membrane. Polymer 2004, 45:5863-5873.
53. Bullen B., Bloxam D.L., Ryder T.A., Mobberley M.A., Bax C.M.R. Two-sided culture of human placental trophoblast. Morphology, immunocytochemistry and permeability properties. Placenta 1990, 11:431-450.
54. Bara A., Bara M. Comparative study of the human amnion, chorion and chorioamnion permeability to monovalent cations. Eur J Obstet Gynecol Reprod Biol 1983, 16:1-7.
55. Seeds A.E., Schruefer J.J., Reinhardt J.A., Garlid K.D. Diffusion mechanisms across human placental tissue. Gynecol Invest 1973, 4:31-37.
56. Moore W.M., Hellegers A.E., Battaglia F.C. In vitro permeability of different layers of the human placenta to carbohydrates and urea. Am J Obstet Gynecol 1966, 96(7):951-955.
57. Welsch F. Human fetal membranes: investigations on membrane potentials and membrane 24Na permeability in vitro and the possible involvement of acetylcholine. Gynecol Obstet Invest 1981, 12(3):113-122.
58. Hardy M., Leonard R.T., Scheide J.I. Cellular permeation pathways in a leaky epithelium: the human amniochorion. Biol Cell 1989, 60:149-153.
59. Lemancewicz A., Laudanaka H., Laudanaski T., Karpiuk A., Batra S. Permeability of fetal membrane to calcium and magnesium: possible role in preterm labour. Humanit Rep 2000, 15(9):2018-2022.
60. Seeds A.E. Osmosis across term human placental membranes. Am J Phys 1970, 219(2):551-554.
61. Wang T., Schneider J. Fine structure of human chorionic membrane. Arch Gynecol Obstet 1983, 233(3):187-198.
62. Verikouki C.H., Hatzoglou C.H., Gourgoulianis K.I., Molyvdas P.A., Kallitsaris A., Messinis I.E. Rapid effect of progesterone on transepithelial resistance of human fetal membranes: evidence for non-genomic action. Clin Exp Pharmacol Physiol 2008, 35:174-179.
63. Utoguchi N., Audus K.L. Carrier-mediated transport of valproic acid in BeWo cells, a human trophoblast cell line. Int J Pharm 2000, 195:115-124.
64. Bajoria R., Ryder T.A., Fisk N.M. Transport and metabolism of thyrotrophin-releasing hormone across the fetal membrane. J Clin Endocrinol Metab 1997, 82(10):3399-3407.
65. Bajoria R., Fisk N.M. Permeability of human placenta and fetal membranes to thyrotropin-stimulating hormone in vitro. Pediatr Res 1998, 43(5):621-628.
66. Aye I.L., Paxton J.W., Evseenko D.A., Keelan J.A. Expression, localisation and activity of ATP binding cassette (ABC) family of drug transporters in human amnion membranes. Placenta 2007, 28(8-9):868-877.
67. Perumal O.P., Inapagolla R., Kannan S., Kannan R.M. The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials 2008, 29(24-25):3469-3476.
68. Lee S., Nam K., Park J.-S., Choi J.S., Eo S.K., Yoo D.J., et al. Extra- and Intranuclear dynamics and distribution of modified-PAMAM polyplexes in living cells: a single-molecule analysis. Bull Korean Chem Soc 2008, 29(8):1565-1568.
69. Patil M.L., Zhang Min, Taratula O., Garbuzenko O.B., He H., Minko T. Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting. Biomacromolecules 2009, 10:258-266.
70. Kurtoglu Y.E., Navath R.S., Wang B., Kannan S., Romero R., Kannan R.M. Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery. Biomaterials 2009, 30(11):2112-2121.
71. Navath R.S., Kurtoglu Y.E., Wang B., Kannan S., Romero R., Kannan R.M. Dendrimer-drug conjugates for tailored intracellular drug release based on glutathione levels. Bioconjugate Chem 2008, 19(12):2446-2455.
72. Wang B., Navath R.S., Romero R., Kannan S., Kannan R.M. Anti-inflammatory and anti-oxidant activity of anionic dendrimer-N-acetyl cysteine conjugates in activated microglial cells. Int J Pharm 2009, 377(1-2):159-168.
73. Kitchens K., El-Sayed M.E.H., Ghandehari H. Transepithelial and endothelial transport of poly (amidoamine) dendrimers. Adv Drug Deliv Rev 2005, 57:2163-2176.